- Home
- RYTM vs FROG Comparison
RYTM vs FROG Comparison
Compare RYTM & FROG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RYTM
- FROG
- Stock Information
- Founded
- RYTM 2008
- FROG 2008
- Country
- RYTM United States
- FROG United States
- Employees
- RYTM N/A
- FROG N/A
- Industry
- RYTM Biotechnology: Pharmaceutical Preparations
- FROG Computer Software: Prepackaged Software
- Sector
- RYTM Health Care
- FROG Technology
- Exchange
- RYTM Nasdaq
- FROG Nasdaq
- Market Cap
- RYTM 6.4B
- FROG 5.8B
- IPO Year
- RYTM 2017
- FROG 2020
- Fundamental
- Price
- RYTM $96.03
- FROG $49.36
- Analyst Decision
- RYTM Strong Buy
- FROG Strong Buy
- Analyst Count
- RYTM 13
- FROG 16
- Target Price
- RYTM $101.92
- FROG $49.13
- AVG Volume (30 Days)
- RYTM 553.4K
- FROG 1.4M
- Earning Date
- RYTM 11-04-2025
- FROG 11-06-2025
- Dividend Yield
- RYTM N/A
- FROG N/A
- EPS Growth
- RYTM N/A
- FROG N/A
- EPS
- RYTM N/A
- FROG N/A
- Revenue
- RYTM $156,287,000.00
- FROG $474,761,000.00
- Revenue This Year
- RYTM $44.69
- FROG $21.24
- Revenue Next Year
- RYTM $63.53
- FROG $15.89
- P/E Ratio
- RYTM N/A
- FROG N/A
- Revenue Growth
- RYTM 53.55
- FROG 21.97
- 52 Week Low
- RYTM $45.91
- FROG $27.00
- 52 Week High
- RYTM $106.52
- FROG $50.98
- Technical
- Relative Strength Index (RSI)
- RYTM 46.64
- FROG 59.62
- Support Level
- RYTM $97.47
- FROG $48.91
- Resistance Level
- RYTM $102.46
- FROG $50.66
- Average True Range (ATR)
- RYTM 3.22
- FROG 1.55
- MACD
- RYTM -1.44
- FROG -0.05
- Stochastic Oscillator
- RYTM 13.52
- FROG 67.07
About RYTM Rhythm Pharmaceuticals Inc.
Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. It is engaged in the development and commercialization of therapies for patients with rare diseases. The company is focused on its melanocortin-4 receptor (MC4R) agonists, including its main asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. Geographically the company generates its revenue from the United States and internationally with the majority being generated from the United States.
About FROG JFrog Ltd.
JFrog Ltd provides an end-to-end, hybrid, universal DevOps Platform that powers and controls the software supply chain, enabling organizations to continuously and securely deliver software updates across any system. Its product portfolio includes JFrog Artifactory; JFrog Pipelines; JFrog Xray; JFrog Distribution; JFrog Artifactory Edge; JFrog Mission Control and JFrog Insight. Geographically, it derives a majority of revenue from Israel and also has its presence in United States, India and other regions.